Health CanadaGeneral Alert
RASILEZ (aliskiren) and RASILEZ HCT (aliskiren/hydrochlorothiazide) - Potential ...
Published: January 23, 2012Recall ID: 24317Category: generalCountry: Canada
Product Description & Identification
RASILEZ (aliskiren) and RASILEZ HCT (aliskiren/hydrochlorothiazide) - Potential Risks of Cardiovascular and Renal Adverse Events in Patients with Type 2 Diabetes - For the Public
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24317 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/rasilez-aliskiren-and-rasilez-hct-aliskirenhydrochlorothiazide-potential-risks |
| Title | RASILEZ (aliskiren) and RASILEZ HCT (aliskiren/hydrochlorothiazide) - Potential Risks of Cardiovascular and Renal Adverse Events in Patients with Type 2 Diabetes - For the Public |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2012-01-23 |
| Organization | Marketed health products |